1 Market Overview

1.1 Product Overview and Scope of Infectious Disease Rapid Diagnostic Testing

1.2 Classification of Infectious Disease Rapid Diagnostic Testing by Type

1.2.1 Overview: Global Infectious Disease Rapid Diagnostic Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type in 2020

1.2.3 Assays

1.2.4 Platforms

1.3 Global Infectious Disease Rapid Diagnostic Testing Market by Application

1.3.1 Overview: Global Infectious Disease Rapid Diagnostic Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Respiratory Infection

1.3.3 Gastro-Intestinal Infection

1.3.4 Center Nervous System Infection

1.3.5 Hospital Acquired Infection

1.3.6 Sexually Transmitted Infections

1.3.7 Others

1.4 Global Infectious Disease Rapid Diagnostic Testing Market Size & Forecast

1.5 Global Infectious Disease Rapid Diagnostic Testing Market Size and Forecast by Region

1.5.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region, (2016-2021)

1.5.3 North America Infectious Disease Rapid Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.6 South America Infectious Disease Rapid Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Infectious Disease Rapid Diagnostic Testing Market Drivers

1.6.2 Infectious Disease Rapid Diagnostic Testing Market Restraints

1.6.3 Infectious Disease Rapid Diagnostic Testing Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.1.4 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Roche Ltd

2.2.1 Roche Ltd Details

2.2.2 Roche Ltd Major Business

2.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.2.4 Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Roche Ltd Recent Developments and Future Plans

2.3 Danaher Corporation

2.3.1 Danaher Corporation Details

2.3.2 Danaher Corporation Major Business

2.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.3.4 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Danaher Corporation Recent Developments and Future Plans

2.4 Luminex Corporation

2.4.1 Luminex Corporation Details

2.4.2 Luminex Corporation Major Business

2.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.4.4 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Luminex Corporation Recent Developments and Future Plans

2.5 BGI Group

2.5.1 BGI Group Details

2.5.2 BGI Group Major Business

2.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.5.4 BGI Group Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BGI Group Recent Developments and Future Plans

2.6 bioMerieux S.A.

2.6.1 bioMerieux S.A. Details

2.6.2 bioMerieux S.A. Major Business

2.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.6.4 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 bioMerieux S.A. Recent Developments and Future Plans

2.7 DiaSorin S.p.A

2.7.1 DiaSorin S.p.A Details

2.7.2 DiaSorin S.p.A Major Business

2.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.7.4 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 DiaSorin S.p.A Recent Developments and Future Plans

2.8 Hologic, Inc.

2.8.1 Hologic, Inc. Details

2.8.2 Hologic, Inc. Major Business

2.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.8.4 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Hologic, Inc. Recent Developments and Future Plans

2.9 Mesa Biotech

2.9.1 Mesa Biotech Details

2.9.2 Mesa Biotech Major Business

2.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.9.4 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Mesa Biotech Recent Developments and Future Plans

2.10 Quidel Corporation

2.10.1 Quidel Corporation Details

2.10.2 Quidel Corporation Major Business

2.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.10.4 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Quidel Corporation Recent Developments and Future Plans

2.11 Thermo Fisher Scientific Inc.

2.11.1 Thermo Fisher Scientific Inc. Details

2.11.2 Thermo Fisher Scientific Inc. Major Business

2.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.11.4 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

2.12 GenMark Diagnostics

2.12.1 GenMark Diagnostics Details

2.12.2 GenMark Diagnostics Major Business

2.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.12.4 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 GenMark Diagnostics Recent Developments and Future Plans

2.13 CTK Biotech

2.13.1 CTK Biotech Details

2.13.2 CTK Biotech Major Business

2.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.13.4 CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 CTK Biotech Recent Developments and Future Plans

2.14 Becton Dickinson

2.14.1 Becton Dickinson Details

2.14.2 Becton Dickinson Major Business

2.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.14.4 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Becton Dickinson Recent Developments and Future Plans

2.15 Cellex Inc.

2.15.1 Cellex Inc. Details

2.15.2 Cellex Inc. Major Business

2.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

2.15.4 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Cellex Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Infectious Disease Rapid Diagnostic Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Infectious Disease Rapid Diagnostic Testing Players Market Share

3.2.2 Top 10 Infectious Disease Rapid Diagnostic Testing Players Market Share

3.2.3 Market Competition Trend

3.3 Infectious Disease Rapid Diagnostic Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Infectious Disease Rapid Diagnostic Testing Revenue and Market Share by Type (2016-2021)

4.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2016-2021)

5.2 Infectious Disease Rapid Diagnostic Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2026)

6.2 North America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2026)

6.3 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country

6.3.1 North America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2026)

6.3.2 United States Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

6.3.3 Canada Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2026)

7.2 Europe Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2026)

7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country

7.3.1 Europe Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2026)

7.3.2 Germany Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.3 France Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.5 Russia Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.6 Italy Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region

8.3.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Region (2016-2026)

8.3.2 China Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.3 Japan Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.5 India Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.7 Australia Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2026)

9.2 South America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2026)

9.3 South America Infectious Disease Rapid Diagnostic Testing Market Size by Country

9.3.1 South America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2026)

9.3.2 Brazil Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country

10.3.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2026)

10.3.2 Turkey Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

10.3.4 UAE Infectious Disease Rapid Diagnostic Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Infectious Disease Rapid Diagnostic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Infectious Disease Rapid Diagnostic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 9. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Roche Ltd Corporate Information, Head Office, and Major Competitors

Table 11. Roche Ltd Major Business

Table 12. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 13. Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 15. Danaher Corporation Major Business

Table 16. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 17. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Luminex Corporation Corporate Information, Head Office, and Major Competitors

Table 19. Luminex Corporation Major Business

Table 20. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 21. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BGI Group Corporate Information, Head Office, and Major Competitors

Table 23. BGI Group Major Business

Table 24. BGI Group Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 25. BGI Group Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. bioMerieux S.A. Corporate Information, Head Office, and Major Competitors

Table 27. bioMerieux S.A. Major Business

Table 28. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 29. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. DiaSorin S.p.A Corporate Information, Head Office, and Major Competitors

Table 31. DiaSorin S.p.A Major Business

Table 32. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 33. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Hologic, Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Hologic, Inc. Major Business

Table 36. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 37. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Mesa Biotech Corporate Information, Head Office, and Major Competitors

Table 39. Mesa Biotech Major Business

Table 40. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 41. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Quidel Corporation Corporate Information, Head Office, and Major Competitors

Table 43. Quidel Corporation Major Business

Table 44. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 45. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Thermo Fisher Scientific Inc. Major Business

Table 48. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 49. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. GenMark Diagnostics Corporate Information, Head Office, and Major Competitors

Table 51. GenMark Diagnostics Major Business

Table 52. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 53. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. CTK Biotech Corporate Information, Head Office, and Major Competitors

Table 55. CTK Biotech Major Business

Table 56. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 57. CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 59. Becton Dickinson Major Business

Table 60. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 61. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Cellex Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Cellex Inc. Major Business

Table 64. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions

Table 65. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) by Players (2019-2021)

Table 67. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Players (2019-2021)

Table 68. Breakdown of Infectious Disease Rapid Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Infectious Disease Rapid Diagnostic Testing Players Head Office, Products and Services Provided

Table 70. Infectious Disease Rapid Diagnostic Testing Mergers & Acquisitions in the Past Five Years

Table 71. Infectious Disease Rapid Diagnostic Testing New Entrants and Expansion Plans

Table 72. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) by Type (2016-2021)

Table 73. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Type (2016-2021)

Table 74. Global Infectious Disease Rapid Diagnostic Testing Revenue Forecast by Type (2021-2026)

Table 75. Global Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021)

Table 76. Global Infectious Disease Rapid Diagnostic Testing Revenue Forecast by Application (2021-2026)

Table 77. North America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Infectious Disease Rapid Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Infectious Disease Rapid Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Infectious Disease Rapid Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Infectious Disease Rapid Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Infectious Disease Rapid Diagnostic Testing Picture

Figure 2. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type in 2020

Figure 3. Assays

Figure 4. Platforms

Figure 5. Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application in 2020

Figure 6. Respiratory Infection Picture

Figure 7. Gastro-Intestinal Infection Picture

Figure 8. Center Nervous System Infection Picture

Figure 9. Hospital Acquired Infection Picture

Figure 10. Sexually Transmitted Infections Picture

Figure 11. Others Picture

Figure 12. Global Infectious Disease Rapid Diagnostic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Infectious Disease Rapid Diagnostic Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2016-2026)

Figure 15. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region in 2020

Figure 16. North America Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Infectious Disease Rapid Diagnostic Testing Market Drivers

Figure 22. Infectious Disease Rapid Diagnostic Testing Market Restraints

Figure 23. Infectious Disease Rapid Diagnostic Testing Market Trends

Figure 24. Abbott Laboratories Recent Developments and Future Plans

Figure 25. Roche Ltd Recent Developments and Future Plans

Figure 26. Danaher Corporation Recent Developments and Future Plans

Figure 27. Luminex Corporation Recent Developments and Future Plans

Figure 28. BGI Group Recent Developments and Future Plans

Figure 29. bioMerieux S.A. Recent Developments and Future Plans

Figure 30. DiaSorin S.p.A Recent Developments and Future Plans

Figure 31. Hologic, Inc. Recent Developments and Future Plans

Figure 32. Mesa Biotech Recent Developments and Future Plans

Figure 33. Quidel Corporation Recent Developments and Future Plans

Figure 34. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 35. GenMark Diagnostics Recent Developments and Future Plans

Figure 36. CTK Biotech Recent Developments and Future Plans

Figure 37. Becton Dickinson Recent Developments and Future Plans

Figure 38. Cellex Inc. Recent Developments and Future Plans

Figure 39. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Players in 2020

Figure 40. Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players Infectious Disease Rapid Diagnostic Testing Revenue Market Share in 2020

Figure 42. Global Top 10 Players Infectious Disease Rapid Diagnostic Testing Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Type in 2020

Figure 45. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Type (2021-2026)

Figure 46. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Application in 2020

Figure 47. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Application (2021-2026)

Figure 48. North America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 49. North America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 50. North America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 51. United States Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 55. Europe Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 56. Europe Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 57. Germany Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2016-2026)

Figure 65. China Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 72. South America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 73. South America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 79. Turkey Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source